Medi Lifestyle Limited AI Stock Analysis
Want to see SG:Z4D full AI Analyst Report?
Medi Lifestyle Limited (Z4D) AI Stock Analysis
Medi Lifestyle Limited
(SGX:Z4D)
Weak financial performance is the dominant factor due to negative equity, losses and cash burn. Bearish technicals and unattractive valuation metrics further pressure the score.
Medi Lifestyle Limited (Z4D) vs. iShares MSCI Singapore ETF (EWS)
- Market Cap
- SGD 19.28M
- Dividend Yield
- ―
- Average Volume (3M)
- 7.51M
- Price to Earnings (P/E)
- -7.3
- Beta (1Y)
- 1.06
- Revenue Growth
- -86.50%
- EPS Growth
- 32.35%
- Country
- Singapore
- Employees
- 156
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Medi Lifestyle Limited Business Overview & Revenue Model
Company Description
Medi Lifestyle Limited is an investment holding firm that offers a range of services, including placement solutions, across Malaysia, Singapore, and China. The company's operations are divided into three core segments: Healthcare, Outsourced Services...
Medi Lifestyle Limited Financial Statement Overview
Summary
Weak financial health with volatile revenue (139% growth in 2025 but 48% TTM decline), persistent negative margins, negative equity at -7.6 million, and consistently negative cash flows indicating high insolvency risk.
Income Statement
20Very NegativeBalance Sheet
10Very NegativeCash Flow
15Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 697.95K | 4.42M | 1.84M | 1.94M | 2.40M | 1.40M |
| Gross Profit | -57.51K | -54.02K | -211.71K | 154.33K | 92.91K | 491.58K |
| EBITDA | -3.71M | -3.71M | -4.69M | -6.18M | -3.49M | -9.15M |
| Net Income | -4.14M | -3.86M | -5.34M | -7.19M | -4.30M | -23.72M |
Balance Sheet | ||||||
| Total Assets | 5.10M | 845.76K | 1.86M | 811.50K | 2.18M | 4.03M |
| Cash, Cash Equivalents and Short-Term Investments | 4.73M | 261.30K | 1.07M | 106.11K | 510.06K | 1.22M |
| Total Debt | 1.24M | 1.20M | 1.57M | 3.84M | 3.53M | 4.96M |
| Total Liabilities | 12.67M | 6.33M | 3.45M | 10.03M | 10.89M | 9.96M |
| Stockholders Equity | -7.57M | -5.48M | -1.59M | -9.22M | -8.71M | -5.93M |
Cash Flow | ||||||
| Free Cash Flow | -2.40M | -3.98M | -6.54M | -6.83M | -2.31M | -4.31M |
| Operating Cash Flow | -2.39M | -3.98M | -6.54M | -6.81M | -2.12M | -4.11M |
| Investing Cash Flow | -4,000 | -3,850 | 0 | -24.83K | -191.16K | -197.61K |
| Financing Cash Flow | 5.82M | 3.18M | 7.54M | 6.38M | 1.44M | 5.02M |
Medi Lifestyle Limited Peers Comparison
Overall Rating
SG:OTX74Outperform
SG:V8Y44Neutral
SG:Z4D39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 74Outperform | SGD 29.60M | 8.72 | 19.60% | 11.45% | -3.11% | -21.50% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 44Neutral | SGD 12.59M | -3.33 | 118.31% | ― | 2.08% | -50.00% | |
| 39Underperform | SGD 29.08M | -7.32 | 70.68% | ― | -86.50% | 32.35% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SG:Z4D | Medi Lifestyle Limited | 0.03 | 0.02 | 240.00% | |
| SG:505 | Asiamedic Limited | 0.02 | -0.00 | -11.11% | |
| SG:FRQ | Singapore Paincare Holdings Limited | 0.06 | -0.10 | -62.03% | |
| SG:OTX | Medinex Ltd. | 0.22 | -0.00 | -1.35% | |
| SG:PRH | Livingstone Health Holdings Limited | 0.02 | -0.01 | -28.57% |
Medi Lifestyle Limited Corporate Events
Medi Lifestyle Discontinues EM2AI Acquisition Term Sheet
Medi Lifestyle Limited and Q & M Dental Group (Singapore) Limited have mutually agreed not to proceed with the proposed acquisition of 60% of EM2AI Pte. Ltd. after the three-month exclusivity period expired on 13 November 2026. No definitive agreemen...
Medi Lifestyle Details Use of S$8.6 Million Share Placement Proceeds
Medi Lifestyle Limited has completed a placement of 178,588,000 new shares, raising net proceeds of about S$8.59 million after expenses. The funds are earmarked for repaying a shareholder loan, supporting general working capital, and financing busine...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 16, 2026
